Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis

Journal of Sexual Medicine

Volumn 7, Issue 6, 2010, Pages 2192-2200

  Lombardi, Giuseppe ^a   Macchiarella, Angelo ^a   Del Popolo, Giulio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Erectile Dysfunction; Multiple Sclerosis; Neurological Disease; Phoshodiesterase Inhibitors; Tadalafil

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; ORAL ANTIDIABETIC AGENT; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; SPASMOLYTIC AGENT; TADALAFIL; VARDENAFIL; VITAMIN;

ADULT; ARTICLE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; FAMILY LIFE; FLUSHING; FOLLOW UP; HEADACHE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYALGIA; NAUSEA; PATIENT ASSESSMENT; PRIORITY JOURNAL; RANK SUM TEST; RHINITIS; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SEXUALITY; SIDE EFFECT; TACHYCARDIA; TREATMENT DURATION; VISUAL DISORDER; WEAKNESS;

EID: 77953936586     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01797.x     Document Type: Article

References (35)

1. Lilius HG, Valltonem EJ, Wilkström J. Sexual problems in patients suffering from multiple sclerosis. Scand J Soc Med 1976, 4:41-4.
2. Betts CD, Jones SJ, Fowler CG, Fowler CJ. Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits and treatment of the condition. Brain 1994, 117:1303-10.
3. Campagnolo DI, Foley FW, Sipski M. Sexual problems in persons with multiple sclerosis. MS Q Rep 2005, 24:5-10. Winter
4. McCabe MP, Mc Donald E, Deeks AA. The impact of multiple sclerosis on sexuality and relationships. J Sex Res 1996, 33:241-8.
5. Landtblom AM. Treatment of erectile dysfunction in multiple sclerosis. Expert Rev Neurother 2006, 6:931-5.
6. Sorgen-Sanders A, Foley FW, La Rocca NG. The multiple sclerosis intimacy and sexuality questionnaire- 19 (MSISQ-19). Sex Disabil 2000, 18:3-24.
7. DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis: Management strategies. Drugs 2003, 63:153-66.
8. Donzè C, Hautecoeur P. Urinary, sexual and bowel disorders in early stage multiple sclerosis. Rev Neurol 2009, 4:155.
9. Kessler TM, Fowler CJ, Panicker JN. Sexual dysfunction in multiple sclerosis. Expert Rev Neurother 2009, 9:341-50.
10. Mattson D, Petrie M, Strivastava DK, Mc Dermott M. Multiple sclerosis and its response to medications. Arch Neurol 1995, 52:862-8.
11. van den Noort S, Holland NJ. Multiple sclerosis in clinical practice 1999, New Work, Demos Medical Publishing Inc
12. Nortvedt MW, Rise T, Mythr KM, Landtblom AM, Bakke A, Nyland HI. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler 2001, 7:231-5.
13. Norvedt M, Riise T, Myhr KM. Quality of life in multiple sclerosis: Measuring the disease effects more broadly. Neurology 1999, 53:1098-103.
14. Levine AM. Management of multiple sclerosis. How to improve the quality of life. Postgrad Med 1985, 77:126-7.
15. Schapiro RT, Langer SL. Symptomatic therapy of multiple sclerosis. Curr Opin Neurol 1994, 7:229-33.
16. Green BG, Martin S. Clinical assessment of sildenafil in the treatment of neurogenic male sexual dysfunction: After the hype. NeuroRehabilitation 2000, 15:101-5.
17. Fowler CJ, Miller JR, Sharief MK, Hussain IF, Stecher VJ, Sweeney M. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005, 76:700-5.
18. Safarinejad MR. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: A double-blind, placebo controlled, randomized study. J Urol 2009, 181:252-8.
19. Goldstein I, Kim E, Steers WD, Pryor JL, Wilde DW, Natanegara F, Wong DG, Ahuja S. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: Results from MOMENTUS: Multiple observations in men with erectile dysfunction in National Tadalafil Study in the US. J Sex Med 2007, 4:166-75.
20. Lombardi G, Macchiarella A, Cecconi F, Del Popolo G. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients. J Sex Med 2009, 6:1248-58.
21. Kurtzke JF. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983, 33:1444.
22. Soler JM, Previnaire JG, Denys P, Chartier-Kastler E. Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men. Spinal Cord 2007, 45:169-73.
23. Giuliano F, Rubio-Aurioles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wilkins HJ, Wachs BH. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Neurology 2006, 66:210-6. Vardenafil Study Group
24. Rubio-Aurioles E, Kim ED, Rosen RC, Porst H, Burns P, Zeigler H, Wong DG. Impact on erectile function and sexual quality of life of couples: A double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. J Sex Med 2009, 6:1314-23.
25. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49:822-30.
26. Fugl-Meyer AR, Ladnert G, Branholm IB. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997, 9:141-8.
27. Wrishko R, Sorsaburu S, Wong D, Strawbridge A, Mc Gilly J. Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil. J Sex Med 2009, 6:2039-48.
28. Zivadinov R, Zorzon M, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Iona LG, Cazzato G. Sexual dysfunction in multiple sclerosis: II. Correlation analysis. Mult Scler 1999, 5:428-31.
29. Hennessey A, Robertson NP, Swingler R, Compston DA. Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol 1999, 246:1027-32.
30. Foley FW, LaRocca NG, Sanders AS, Zemon V. Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis. Mult Scler 2001, 7:417-21.
31. Rees PM, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet 2007, 369:512-25.
32. Staerman F, Guiraud P, Coeurdacier P, Menard D, Edan G, Lobel B. Value of nocturnal penile tumescence and rigidità (NPTR) recording in impotent patients with multiple sclerosis. Int J Impot Res 1996, 8:241-5.
33. Fletcher SG, Castro-Borrero W, Remington G, Treadaway K, Lemack GE, Frohman EM. Sexual dysfunction in patients with multiple sclerosis: A multidisciplinary approach to evaluation and management. Nat Clin Pract Urol 2009, 6:96-107.
34. Crayton HJ, Rossman HS. Managing the symptoms of multiple sclerosis: A multimodal approach. Clin Ther 2006, 28:445-60.
35. Landtblom AM. [Support permanent discount for Viagra and Cialis in MS! Specified subsidy according to the Danish model is justified]. Lakartidningen 2004, 101:2666-7.